Abstract: Effect of hydrogen therapy on the proteomic profile of exhaled breath condensate after recovery from COVID-19
by Alexander Brzhozovskiy, Alexander Chuchalin, Alexey Kononikhin, Anna Kozyr, Anna Ryabokon, Eugene Nikolaev, Ludmila Shogenova, Maria Indeykina, Natalia Zakharova, Sergey Varfolomeev
Abstract:
Exhaled breath condensate (EBC) is a promising object for biomarkers search as it contains compounds reflecting changes of biological processes caused by various respiratory diseases including COVID-19. Molecular hydrogen was recently discovered as a new effective antioxidant that can restore lung function after COVID-19. The effect of molecular hydrogen on lung function was studied by comparing EBC protein profiles before and after hydrogen therapy in volunteers who had recovered from COVID-19. Total 108 EBC samples were collected with RTube devices from recovered volunteers before and after hydrogen inhalation. The collecting tube was additionally rinsed with methanol. Peptides obtained after tryptic digestion were analyzed by LC-MS/MS using a nano-LC Dionex system coupled to tims TOF Pro (Bruker) tandem high-resolution mass-spectrometer located in Skoltech. Totally 478 proteins and 1350 peptides were revealed. It was shown that in EBC of the group after the hydrogen therapy, the concentration of structural and protective proteins increased significantly, as well as the average number of detected proteins increased by 15% (from 349 to 398), and the intensity of the 36 most common proteins increased ~3 times compared with the group, which did not receive the therapy. Dermcidin, an antibiotic and proteolytic protein, was found one of the most often found proteins in the group after therapy. Overall, mass spectrometry based analysis showed both quantitative and qualitative EBC proteome changes before and after the hydrogen therapy. This work was partially supported by the RFBR grant 18-29-09158 MK.
Read more:
https://doi.org/10.1183/13993003.congress-2021.OA4115
Related Articles:
Background: Activated inflammatory cells produce reactive oxygen species (ROS) to eliminate pathogens. Under normal conditions, the pathogens are taken care of, and tissues are repaired. However, in periodontal disease, persistent inflammation causes increased ROS release and impaired healing. Therefore, removal…
Objective: To investigate the effect of hydrogen gas on NOD-like receptor protein 3 (NLRP3) inflammasomes in the cerebral cortex of rats with traumatic brain injury (TBI). Methods: 120 adult male Sprague-Dawley (SD) rates were randomly divided into 5 groups (n…
Background: Hydrogen/oxygen therapy contribute to ameliorate dyspnea and disease progression in patients with respiratory diseases. Therefore, we hypothesized that hydrogen/oxygen therapy for ordinary coronavirus disease 2019 (COVID-19) patients might reduce the length of hospitalization and increase hospital discharge rates. Methods:…
Introduction: With the global population aging, there is an increased prevalence of sepsis among the elderly, a demographic particularly susceptible to inflammation. This study aimed to evaluate the therapeutic potential of hydrogen gas, known for its anti-inflammatory and antioxidant properties,…
Clinical studies had found that hydrogen/oxygen mixed inhalation was beneficial to ameliorate the respiratory symptoms in the adjuvant treatment of patients with COVID-19. We aimed to explore the efficacy of hydrogen/oxygen therapy in favoring the recovery of Omicron SARS-CoV-2 variant…
Traumatic brain injury (TBI) has been recognized as a serious public health issue and a key contributor to disability and death, with a huge economic burden worldwide. Hydrogen, which is a slight and specific cytotoxic oxygen radical scavenger, has been…
0 Comments